• Highlights from ESMO 2023
  • Podcast Series: Discussions on NCCN Guidelines for MCL and CLL
  • Case Study: How Would You Treat…
  • Podcast Series: Discussions on CLL
  • And the Diagnosis is…
  • Highlights from ASCO 2024: Focus On Endometrial Cancer
  • HRD Testing in Advanced Ovarian Cancer
  • Patient-Matched Tumor-Normal Sequencing
  • Transforming colorectal cancer management with tumor informed ctDNA testing

Advanced Search

  • Featured:
  • Genomic Profiling in Advanced Cancer Therapy Selection
  • Highlights from ESMO 2026
  • Challenge One
  • Challenge Two

Challenge your diagnostic skills

Answer each quiz question to better understand the patient’s journey and determine the correct diagnosis.


  • 1 Question 1
  • 2 Question 2
  • 3 Question 3
  • 4 Final diagnosis
Question 3

Question 3 of 3 – Select the correct answer

Immunophenotyping of peripheral blood and karyotype analysis were performed as the next steps in the diagnostic workup.

  • Immunophenotyping of the peripheral blood by flow cytometry: showed 80% abnormal B cells that were positive for pan B-cell markers (CD19, cytoplasmic CD79a, CD20, and cytoplasmic CD22), CD45 (bright), human leukocyte antigen DR isotype (HLA-DR), cytoplasmic CD79b, CD10 (dim), and CD200. They were negative for CD3, CD5, CD7, CD34, TdT, CD103, CD38, surface CD22, surface CD79b, FMC7, and CD30.
  • Karyotype analysis: Examination of 20 metaphases showed a complex karyotype with some missing chromosomes, deletions, and translocations: 42,X,-X,del(1)(q36), t(4;17)(q27;q25),-8, t(12;21)(q24;q22),-14,-18, and del(19)t(9;19)(q11;p11)(20).

These findings, along with the clinical and radiologic data, suggested an unusual immunophenotype that posed a diagnostic challenge.

Choose your next step:

Continue
  • Previous
  • Next

© Copyright 2026. All Rights Reserved. Privacy Policy |

Wolter Kluwer